Patents/Assignees

Abcuro, Inc.

1 patent in portfolio

US12139541utility2024
Methods of Treating Disorders Associated with Excess or Unwanted Killer Cell Lectin-like Receptor Subfamily G Member 1 (KLRG1) Expressing T Cells with KLRG1 Depleting Antibodies
0 cites